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In obesity, anorectic responses to leptin are dimin-
ished, giving rise to the concept of ‘‘leptin resis-
tance.’’ Increased expression of protein tyrosine
phosphatase 1B (PTP1B) has been associated with
the attenuation of leptin signaling and development
of cellular leptin resistance. Here we report that
hypothalamic levels of the tyrosine phosphatase
TCPTP are also elevated in obesity to attenuate the
leptin response. We show that mice that lack TCPTP
in neuronal cells have enhanced leptin sensitivity and
are resistant to high-fat-diet-induced weight gain
and the development of leptin resistance. Also, intra-
cerebroventricular administration of a TCPTP inhib-
itor enhances leptin signaling and responses in
mice. Moreover, the combined deletion of TCPTP
and PTP1B in neuronal cells has additive effects in
the prevention of diet-induced obesity. Our results
identify TCPTP as a critical negative regulator of
hypothalamic leptin signaling and causally link ele-
vated TCPTP to the development of cellular leptin
resistance in obesity.
INTRODUCTION
Leptin is an important hormone that integrates peripheral energy
stores with the central adaptive control of energy expenditure for
survival and reproductive fitness. Leptin acutely decreases food
intake and body weight, increases energy expenditure in lean
humans and animals, and reverses obesity and the associated
pathologies in leptin-deficient rodents and humans (Myers
et al., 2008). However, leptin responsiveness decreases with684 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 Elsevierincreasing adiposity, and obese rodents and humans are resis-
tant to the effects of leptin on body weight (Myers et al., 2008).
The decreased leptin sensitivity in obesity is associated with
alterations in varied cellular and molecular processes that atten-
uate the leptin signal (Myers et al., 2008). Therefore, approaches
that enhance leptin signaling may be effective in overcoming
cellular leptin resistance and combating obesity.
Leptin acts in several regions of the hypothalamus, including
the arcuate nucleus (ARC), the ventromedial hypothalamus
(VMH), and the dorsomedial hypothalamus (DMH), to regulate
body weight and glucose homeostasis (Myers et al., 2008). In
the ARC, leptin acts on anorexigenic pro-opiomelanocortin
(POMC; the precursor of a-melanocyte-stimulating hormone,
a-MSH) and orexigenic neuropeptide Y (NPY)- and agouti-
related peptide (AgRP)-expressing neurons. POMC expression
is increased by leptin, whereas AgRP (antagonizes a-MSH
binding tomelanocortin receptors) andNPY levels are decreased
(Cowley et al., 2001; Elias et al., 1999). These changes in neuro-
peptide expression serve to decrease food intake and increase
locomotor activity and metabolic rate to enhance weight loss
and glucose homeostasis (Myers et al., 2008).
Leptin signals by binding to the leptin receptor (LEPR-B) to
activate the tyrosine kinase JAK2 (Janus-activated kinase 2),
which in turn phosphorylates LEPR-B and promotes signaling
via several effector cascades, including the Ras/mitogen-acti-
vated protein kinase (MAPK), phosphatidylinositol 3-kinase
(PI3K)/Akt, and STAT3 (signal transducer and activator of tran-
scription 3) pathways (Myers et al., 2008). The STAT3 pathway
is particularly critical and necessary for the effects of leptin on
food intake and body weight (Bates et al., 2003; Myers et al.,
2008). STAT3 is recruited to the LEPR-B and is phosphorylated
by JAK2 on Y705, allowing for STAT3 dimerization and translo-
cation to the nucleus to mediate gene transcription. The activa-
tion of STAT3 stimulates POMC expression and suppresses
AgRP expression (Myers et al., 2008); other leptin-activated
pathways regulate the expression of NPY (Bates et al., 2003).Inc.
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been implicated in the development of cellular leptin resistance:
protein tyrosine phosphatase (PTP) 1B (PTP1B; encoded by
Ptpn1) and suppressor of cytokine signaling-3 (SOCS3). PTP1B
is localized on the cytoplasmic face of the endoplasmic reticulum
(ER) and attenuates leptin signaling by dephosphorylating and in-
activating JAK2 (Myers et al., 2001), but not STAT3 (Cheng et al.,
2002). Whole-body- (Ptpn1–/–), brain- (Ptpn1loxlox;Nestin-Cre), or
POMC neuron-specific (Ptpn1loxlox;Pomc-Cre)-PTP1B knockout
mice exhibit leptin hypersensitivity, increased energy expendi-
ture and insulin sensitivity, and resistance to diet-inducedobesity
(DIO) (Banno et al., 2010; Bence et al., 2006; Cheng et al., 2002;
Elchebly et al., 1999; Klaman et al., 2000; Zabolotny et al., 2002).
Furthermore, hypothalamic PTP1B knockdown with antisense
oligonucleotides or intracerebroventricular (i.c.v.) administration
of PTP1B inhibitors enhance leptin sensitivity, decrease weight
gain, and improve insulin sensitivity in rodent models of obesity
(Morrison et al., 2007; Picardi et al., 2008), validating hypotha-
lamic PTP1B as a therapeutic target for the treatment of the
disease. SOCS3 attenuates leptin signaling by binding and inhib-
iting JAK2 and by targeting the LEPR-B complex, or components
thereof, for proteasomal degradation (Myers et al., 2008). Socs3
is a transcriptional target for STAT3, and hypothalamic Socs3
levels are increased after leptin administration, consistent with
SOCS3 acting in a negative feedback loop (Bjørbaek et al.,
1998). As for PTP1B, whole-brain- or neuronal cell-specific
Socs3 knockout mice exhibit enhanced leptin sensitivity and
resistance to DIO (Kievit et al., 2006; Mori et al., 2004). PTP1B
andSOCS3 levels are elevated in obesity, driven in part by the hy-
perleptinemia, which is characteristic of the obese state, as well
as by the inflammation and ER stress that are important in the
etiology of cellular leptin resistance and the pathology of obesity
(Bjørbaek et al., 1998; Morrison et al., 2007; Ozcan et al., 2009;
Zabolotny et al., 2008; Zhang et al., 2008).
Although PTP1B and SOCS3 are important negative regula-
tors of hypothalamic leptin signaling, and increases in PTP1B
and SOCS3 expression contribute to the development of cellular
leptin resistance, deletion of either (Bence et al., 2006; Mori
et al., 2004) or both (Briancon et al., 2010) in neuronal cells
reduces, but does not prevent, DIO in mice. Thus, additional
molecular factors might contribute to the development of
cellular leptin resistance and DIO. T cell PTP (TCPTP; encoded
by Ptpn2) is closely related to PTP1B, sharing a high degree of
primary (72% identity) and tertiary structural similarity (Tiganis
and Bennett, 2007). Despite this, PTP1B and TCPTP exhibit
exquisite substrate selectivity in vivo; for example, PTP1B
dephosphorylates JAK2, but not JAK1/3, and TCPTP dephos-
phorylates JAK1/3, but not JAK2 (Myers et al., 2001; Simoncic
et al., 2002; Zabolotny et al., 2002). Moreover, alternative
splicing of Ptpn2 message can give rise to two TCPTP variants:
a 48 kDa TCPTP (TC48) that is targeted to the ER and a 45 kDa
variant (TC45) that shuttles in and out of the nucleus; nuclear
substrates of TCPTP include STAT3 (Shields et al., 2008; Tiganis
and Bennett, 2007; Yamamoto et al., 2002). Here we identify
TCPTP as an integral negative regulator of leptin-induced
STAT3 signaling. We report that hypothalamic TCPTP levels
are increased in obesity, acting together with elevated PTP1B
in the attenuation of the leptin signal and the development of
cellular leptin resistance.Cell MRESULTS
Hypothalamic TCPTP Is Increased in Obesity
As a first step toward elucidating TCPTP’s role in the central
control of body weight and energy homeostasis, we assessed
TCPTP expression in the hypothalami of lean versus high-fat-
fed (HFF; 23% fat [45% energy from fat]) obese C57BL/6 mice.
TCPTP was expressed in the hypothalami of mice and detected
in the ARC, VMH, DMH, lateral hypothalamus (LH), and paraven-
tricular nucleus (PVN) (Figure 1A). Hypothalamic TCPTP (TC48
and TC45) protein levels were increased by as much as 2-fold
in HFF obese mice (Figure 1B). Consistent with previous studies,
we noted similar increases in hypothalamic PTP1B and SOCS3
levels (Figure 1B). The increase in TCPTP protein coincided
with a 1.4-fold increase in Ptpn2message as assessed by quan-
titative real-time PCR (Figure 1C). By contrast, TCPTP protein
levels were not altered in skeletal muscle, liver, or fat from obese
mice (Figure S1). Moreover, TCPTP expression was not elevated
in the hypothalami of chow-fed leptin-deficient (Ob/Ob) obese
mice when compared to lean (Ob/+) controls (Figure 1B). There-
fore, the hyperleptinemia in DIO might be responsible for the
elevated hypothalamic TCPTP protein. To test this directly, we
determined whether leptin administration could promote TCPTP
expression in CHO cells stably overexpressing the leptin re-
ceptor (CHO-LEPR-B). TCPTP expression was increased by
approximately 2-fold in response to leptin, and this could be pre-
vented if CHO-LEPR-B cells were pretreated with the protein
synthesis inhibitor cycloheximide (Figures 1D and 1E). We also
determined if TCPTP expression could be induced by leptin
in vivo. Leptin was administered to 8-week-old C57BL/6 mice,
and hypothalamic Ptpn2 message and TCPTP protein levels
were determined. Leptin treatment resulted in a transient in-
crease in Ptpn2 message within 2 hr of administration, and
repeated dosing increased TCPTP protein in the hypothalamus
(Figures 1F and 1G). Therefore, these results indicate that TCPTP
expression can be induced by leptin and that the elevated hypo-
thalamic TCPTP in the HFF obese state is driven by the accom-
panying hyperleptinemia.
Neuronal TCPTP-Deficient Mice
To determine if TCPTP has a role in the central control of
body weight and glucose homeostasis in vivo, we generated
a floxed allele of Ptpn2 (loxP sites flanking exons 5 and 6 encod-
ing the core of the catalytic domain, including the catalytically
essential Asp182 and Cys216 residues; Figure S2). Ptpn2lox/lox
(C57BL/6) mice were crossed with mice expressing the Cre re-
combinase under the control of the Nestin promoter (Nes-Cre;
C57BL/6) to excise Ptpn2 in neuronal cells. TCPTP expression,
as assessed by immunoblot analysis, was ablated in brain in
Nes-Cre;Ptpn2lox/lox mice, but not in pancreas, kidney, liver,
fat, muscle, or bone marrow (Figure 2A; data not shown). TCPTP
deletion did not result in a compensatory increase in PTP1B in
the hypothalami of chow-fed mice (data not shown).
Body weights in 3-week-old Nes-Cre;Ptpn2lox/lox mice were
approximately 20% lower than those of Ptpn2lox/lox control
littermates (Figure 2B). No overt difference in body weight was
evident in heterozygous Nes-Cre;Ptpn2lox/+ compared to
Ptpn2lox/lox male mice, and no difference was noted between
Nes-Cre;Ptpn2+/+ and Ptpn2+/+ littermate controls (Figure 2C),etabolism 14, 684–699, November 2, 2011 ª2011 Elsevier Inc. 685
Figure 1. TCPTP Expression Is Elevated in Obesity and Is Induced by Leptin
(A) Extracts of whole brain, hypothalamus, and microdissected ARC, VMH, DMH, LH, cortex, and PVN were processed for immunoblot analysis.
(B) Hypothalamic extracts from chow-fed versus HFF C57BL/6 male mice or chow-fed Ob/+ lean versus leptin-deficient chow-fed Ob/Ob obese mice were
processed for immunoblot analysis.
(C) Hypothalami were extracted from chow-fed versus C57BL/6 mice and processed for quantitative real-time PCR to measure Ptpn2 expression.
(D and E) CHO-LEPR-B cells were serum starved for 12 hr, left untreated or pretreated with 10 mg/ml cycloheximide (CHX) for 4 hr, stimulated with 10 ng/mlmurine
leptin for the indicated times, and processed for immunoblot analysis.
(F and G) Eight-week-old C57BL/6 mice were fasted for 18 hr and administered leptin (5 mg/g i.p.), and hypothalami were extracted at the indicated times
and processed for real-time PCR to measure Ptpn2 expression (F), or they were administered leptin (every 2 hr for 16 hr) and hypothalami were ex-
tracted for immunoblot analysis (G). Results in (A) are representative of two and (B)–(G) of at least three independent experiments; quantified results are
means ± SEM.
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TCPTP and Leptin Sensitivityconsistent with the difference in size being due to TCPTP defi-
ciency rather than the Nes-Cre transgene. This difference in
body weight was evident in male and female mice and persisted
in older mice, coinciding with significant decreased body length
(Figures 2B, 2D, and S3A). Corresponding tissue weights
also were lower in Nes-Cre;Ptpn2lox/lox mice, but normalized
when corrected for total body weight, consistent with Nes-
Cre;Ptpn2lox/lox mice being proportionately smaller (Figure 2E).
Dual-energy X-ray absorptiometry (DEXA) in 8-week-oldmice re-
vealed that lean mass (tissues other than bone and fat) was
reduced, but normal when corrected for body weight (Figure 2F).686 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 ElsevierBy contrast, bone mineral density was reduced and remained
lower when normalized for body weight (Figure 2F). The de-
crease in bone mineral density was associated with a decrease
in trabecular bone volume and decreased bone marrow cellu-
larity (Figures S3B and S3C). A decrease in bone mineral content
has been noted previously in neuronal cell-specific (Nes-
Cre;Ptpn1lox/lox) PTP1B knockout mice (Bence et al., 2006) and
is consistent with leptin hypersensitivity and the established
potential of hypothalamic leptin signaling to inhibit bone forma-
tion via the sympathetic control of osteoblasts (Takeda, 2005).
We found that fat mass as determined by DEXA was unalteredInc.
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TCPTP and Leptin Sensitivityin male Nes-Cre;Ptpn2lox/lox versus Ptpn2lox/lox mice and de-
creased in female Nes-Cre;Ptpn2lox/lox mice, but relative adi-
posity (corrected for body weight) in Nes-Cre;Ptpn2lox/lox mice
was increased irrespective of gender (Figures 2F and S3B).
The increased relative adiposity coincided with decreased am-
bulatory activity but increased oxygen consumption and energy
expenditure and decreased daily food intake (Figures 2G, S3E
and S3F).
Altered GH/IGF-1 Axis in Neuronal TCPTP-Deficient
Mice
Growth hormone (GH) regulates important physiological pro-
cesses acting directly and indirectly, through insulin-like growth
factor (IGF)-1, to regulate growth and development as well as
carbohydrate and lipid metabolism (Lichanska and Waters,
2008). GH is released from the anterior pituitary and signals
via JAK2 and STAT5 to promote lipolysis in fat and IGF-1
production in the liver (Lichanska and Waters, 2008). Impor-
tantly, GH and IGF-1 feed back onto somatotrophs as well as
hypothalamic neurons to repress GH-releasing hormone
(GHRH) and stimulate somatostatin expression, thereby inhibit-
ing GH release (Becker et al., 1995; Burton et al., 1992; Minami
et al., 1993; Romero et al., 2010). Somatostatin levels are
decreased in STAT5b-deficient mice (Bennett et al., 2005),
consistent with STAT5 being important in the feedback regula-
tion of GH production. Cell-based studies have shown that
Y694-phosphorylated STAT5 can serve as a TCPTP substrate
(Aoki and Matsuda, 2002; Simoncic et al., 2002). As GH defi-
ciency in rodents and humans is associated with dwarfism
and increased adiposity (Lichanska and Waters, 2008), we
asked whether the GH/IGF-1 axis was perturbed in Nes-Cre;
Ptpn2lox/lox mice. We found that circulating GH and IGF-1 levels
(from fed mice at 8 a.m.) were reduced in Nes-Cre;Ptpn2lox/lox
mice (Figure 2H), coinciding with elevated hypothalamic
GH-induced STAT5 Y694 phosphorylation (Figure 2I) and
reduced Ghrh expression (Figure 2J). These results are consis-
tent with neuronal TCPTP deficiency affecting the GH/IGF-1
axis and with the decreased size and the increased relative
adiposity in Nes-Cre;Ptpn2lox/lox mice being due to lower circu-
lating GH.
Enhanced Leptin Sensitivity in Neuronal
TCPTP-Deficient Mice
Central leptin signaling lowers plasma leptin by decreasing fat
mass through the control of appetite and energy expenditure
and by increasing sympathetic activity to adipose tissue to
both promote lipolysis and inhibit leptin gene expression (Bart-
ness et al., 2010; Commins et al., 2000; Myers et al., 2008).
Despite the increased relative adiposity, chow-fed 8-week-old
male and female Nes-Cre;Ptpn2lox/lox mice had decreased fed
plasma leptin levels compared with controls (Figures 3A and
S4A). Plasma adiponectin, which is produced by fat, inversely
correlates with fat mass, and promotes insulin sensitivity (Shetty
et al., 2009), was unaltered by TCPTP deficiency in chow-fed
mice (Figure 3A), indicating that adipokine production was not,
in general, altered. The lower leptin levels in the face of
increased relative adiposity in conjunction with decreased
food intake and increased energy expenditure are consistent
with a significant enhancement in central leptin sensitivity. ToCell Mdirectly examine leptin sensitivity, we administered leptin to 8-
to 10-week-old Nes-Cre;Ptpn2lox/lox and Ptpn2lox/lox littermates
in the mornings and evenings for 3 consecutive days and re-
corded body weights and food intake daily. The effects of leptin
on body weight and food intake were enhanced in male and
female Nes-Cre;Ptpn2lox/lox mice (Figures 3B, 3C, and S4B).
By contrast, leptin-induced changes in body weight were not
altered in Nes-Cre;Ptpn2lox/+ compared to Ptpn2lox/+ heterozy-
gous mice (Figure 3D). The elevated leptin sensitivity in
Nes-Cre;Ptpn2lox/lox mice coincided with enhanced hypotha-
lamic leptin signaling (as assessed by immunoblot [Figure 3E]
or immunohistochemical [Figure 3F] analysis). Hypothalamic
STAT3 Y705 phosphorylation, but not JAK2 Y1007/Y1008 or
Akt Ser473 phosphorylation, was increased in Nes-Cre;
Ptpn2lox/lox male and female mice after bolus leptin administra-
tion (Figures 3E and S4C). Basal STAT3 phosphorylation was
increased significantly in the ARC, whereas leptin-induced
phosphorylation was elevated in the ARC and VMH, but not
the DMH (Figure 3F). These results are consistent with TCPTP
selectively regulating leptin signaling in hypothalamic nuclei
and demonstrate that TCPTP deficiency enhances leptin
signaling in nuclei that are essential for the control of body
weight and metabolism.
Selective Regulation of STAT3 Signaling
To determine how TCPTP affects leptin sensitivity in vivo, we
examined TCPTP’s capacity to regulate leptin signaling
in vitro. Overexpression of TC45 in LEPR-B-expressing CHO
cells suppressed leptin-induced STAT3 Y705 phosphorylation
(Figure 4A), but did not significantly alter JAK2 Y1007/Y1008
phosphorylation or downstream PI3K/Akt signaling, as as-
sessed by Akt Ser473 phosphorylation (Figure 4A), consistent
with TC45 acting selectively on STAT3. To determine the
subcellular compartment in which TC45 dephosphorylates
STAT3 in response to leptin, we took advantage of the TC45-
D182A ‘‘substrate-trapping’’ mutant, which forms stable
complexes with tyrosine-phosphorylated substrates in a cellular
context and prevents their dephosphorylation from endogenous
phosphatases (Tiganis and Bennett, 2007; Tiganis et al., 1998).
Expression of TC45-D182A in LEPR-B-expressing CHO cells re-
sulted in the nuclear accumulation of Y705-phosphorylated
STAT3 (Figure 4B), consistent with TC45 dephosphorylating
STAT3 in the nucleus. In addition, TC45-D182A was not evident
in the cytoplasm (Figure 4B), consistent with TC45 acting
exclusively on nuclear substrates. To complement the overex-
pression studies, we stably knocked down TCPTP by RNA
interference in SK-N-SH-SY5Y neuroblastoma cells. TCPTP
knockdown resulted in elevated leptin-induced STAT3 phos-
phorylation but, importantly, did not affect the activation of
the Ras/MAPK pathway (ERK1/2 phosphorylation; Figure 4C),
which occurs downstream of JAK2 and in parallel to the
STAT3 pathway; high basal JAK2 and Akt phosphorylation
precluded any assessment of leptin-induced JAK2/Akt signaling
in SK-N-SH-SY5Y cells (Figure 4C). Finally, TCPTP knockdown
resulted in enhanced nuclear (but not cytoplasmic) accumula-
tion of phosphorylated STAT3 (Figure 4D). Taken together,
these results are consistent with TCPTP attenuating leptin-
induced STAT3 signaling through the selective dephosphoryla-
tion of STAT3.etabolism 14, 684–699, November 2, 2011 ª2011 Elsevier Inc. 687
Figure 2. Generation of Neuronal Cell TCPTP-Deficient Mice
(A) TCPTP protein levels in Ptpn2lox/lox control (lox/lox) and Nes-Cre;Ptpn2lox/lox neuronal cell TCPTP knockout (NTKO) mice.
(B and C) Body weights in 3- to 20-week-old male lox/lox, Nes-Cre;Ptpn2lox/+ (Cre;lox/+), NTKO, Ptpn2+/+ (+/+), and Nes-Cre;Ptpn2+/+ (Cre;+/+) mice.
(D and E) Nose to tail body lengths in 8-week-old (D) and tissue weights in 8- to 10-week-old (E) male lox/lox and NTKO mice.
(F and G) Body composition (lean, fat, bone mineral content [BMC] and bone mineral density [BMD]) measured by DEXA and normalized to total body weight (F)
and light and dark cycle oxygen consumption, energy expenditure, ambulatory activity (x and z axes) and daily food intake (G) in 8- to 10-week-old lox/lox and
NTKO mice.
(H) Fed serum GH and IGF-1 levels (collected at 8 a.m.) from 8-week-old male lox/lox and NTKO mice.
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TCPTP and Leptin SensitivityTCPTP Deficiency Affects Pomc and Agrp but Not Npy
Expression
Leptin suppresses the expression of the orexigenic neuropep-
tides NPY andAgRP and promotes the expression of the anorex-
igenic neuropeptide POMC (Myers et al., 2008). Mice were
fasted for 18 hr, and hypothalamic Pomc, Agrp, andNpy expres-
sion was assessed by quantitative real-time PCR before and 2 hr
after bolus leptin (5 mg/g i.p.) administration. Basal hypothalamic
Pomc levels were elevated in Nes-Cre;Ptpn2lox/lox mice, consis-
tent with enhanced leptin sensitivity (Figure 3G). Fasted levels of
hypothalamic Agrp were also increased, similar to the effects of
neuronal PTP1B deficiency (Bence et al., 2006), possibly repre-
senting a compensatory response to neuronal TCPTP defi-
ciency. Nevertheless, neuronal TCPTP deficiency exaggerated
the effects of leptin on Pomc and Agrp expression, consistent
with enhanced leptin sensitivity; Npy expression was not altered
by TCPTP deficiency (Figure 3G). To exclude any extrinsic influ-
ences on leptin sensitivity and neuropeptide expression, we also
measured the secretion of a-MSH and NPY ex vivo using hypo-
thalamic blocks prepared from Nes-Cre;Ptpn2lox/lox and
Ptpn2lox/lox mice (Figure 3H). Leptin-induced a-MSH secretion
ex vivo was increased significantly by TCPTP deficiency,
whereas NPY secretion was decreased comparably by leptin
with or without TCPTP (Figure 3H). Taken together, these results
are consistent with neuronal cell TCPTP deficiency enhancing
the effects of leptin on neuropeptide expression to alter food
intake and body weight. Moreover, given the specific alterations
in POMC/a-MSH and AgRP but not NPY, these results are
consistent with TCPTP exerting its effects via STAT3 (Bates
et al., 2003).
Inhibition of Neuronal TCPTP Enhances Leptin
Sensitivity
We sought to establish an independent model by which to
assess the role of TCPTP in the central control of body weight.
We took advantage of the highly specific and cell-permeable
TCPTP inhibitor, compound 8 (Zhang et al., 2009). This pharma-
cological inhibitor is 8-foldmore selective for TCPTP over PTP1B
and exhibits greater than 200-fold selectivity for TCPTP over
other PTPs (Zhang et al., 2009). Compound 8 (1.5 ml, 0.2 nmol)
or vehicle control (artificial cerebrospinal fluid [aCSF]) was
administered (i.c.v.) into 12-week-old fasted C57BL/6 mice,
andmice were then injected with leptin (1 mg/g i.p.). Hypothalami
were extracted and processed for immunoblot analysis. Admin-
istration of TCPTP inhibitor increased leptin-induced STAT3
phosphorylation by more than 3-fold (Figure 5A). Next we as-
sessed the effects of compound 8 on body weight, oxygen
consumption, and energy expenditure. C57BL/6 mice were
administered compound 8 (i.c.v.) followed by leptin (0.5 mg/g
i.p.) at 7 a.m. and 7 p.m. for 2 consecutive days, and body
weights, oxygen consumption, and energy expenditure were re-
corded. Compound 8 significantly enhanced the effects of leptin
on body weight (Figure 5B) and increased oxygen consumption(I) Eight-week-old male lox/lox and NTKO mice were fasted for 18 hr and injected
immunoblot analysiswithantibodies toY1007/Y1008phosphorylatedJAK2 (p-JAK2
(J) Hypothalami were extracted from 8-week-old male lox/lox and NTKO mice
expression. Results in (A)–(G) are representative of at least three and in (H)–(J) two
number of mice.
Cell Mand energy expenditure (Figure 5C). Importantly, compound 8
did not enhance the effects of leptin (0.25–0.5 mg/g i.p.) on
body weight in Nes-Cre;Ptpn2lox/lox mice (Figures 5D and S4D),
consistent with the inhibitor acting via the specific inhibition of
TCPTP in neuronal cells. Taken together, these results confirm
that TCPTP has a key role in the control of leptin sensitivity.
Glucose Homeostasis in Neuronal TCPTP-Deficient
Mice
We found that insulin sensitivity and whole-body glucose utiliza-
tion, as assessed in insulin tolerance tests (ITTs) and glucose
tolerance tests, respectively, were increased in male Nes-Cre;
Ptpn2lox/lox mice (Figure S5A); insulin sensitivity also was
increased in female Nes-Cre;Ptpn2lox/lox compared with control
mice (Figure S5B). The enhanced insulin sensitivity in male and
female Nes-Cre;Ptpn2lox/lox mice coincided with significantly
reduced fasted blood glucose levels and reduced fasted plasma
insulin (Figures S5C and S5D). No differences in insulin sensi-
tivity were noted in Nes-Cre;Ptpn2lox/+ versus Ptpn2lox/+ mice
(Figure S5E). Therefore, TCPTP deficiency promotes leptin
sensitivity and enhances peripheral insulin sensitivity despite
the increased relative adiposity.
Obesity Resistance in Neuronal TCPTP-Deficient Mice
Next, we assessed the impact of neuronal TCPTP deficiency on
DIO and the development of leptin and insulin resistance. Eight-
week-old male Nes-Cre;Ptpn2lox/lox and Ptpn2lox/lox mice were
fed a high-fat diet (23% fat) for 12 weeks. The incremental in-
crease in body weight over the 12 weeks of high-fat feeding
was reduced significantly by TCPTP deficiency (Figure 6A).
DEXA revealed that this was associated with a decrease in fat
accumulation (Figure 6B). In contrast to 8-week-old (Figure 2F)
or similarly aged chow-fed mice (data not shown), where the
percent fat mass was increased by TCPTP deficiency, total fat
masswas reduced inHFFNes-Cre;Ptpn2lox/lox versusPtpn2lox/lox
mice, so that their relative adiposity was identical (Figure 6B);
relative lean mass remained unaltered whereas bone density
was reduced (Figure 6B), as seen in chow-fed mice (Figure 2F).
Although Nes-Cre;Ptpn2lox/lox mice on a high-fat diet developed
cellular leptin resistance (when compared to similarly aged
chow-fed mice; data not shown), the effects of leptin on body
weight continued to be enhanced by TCPTP deficiency
(Figure 6C), and this was accompanied by increased leptin-
induced STAT3 phosphorylation (Figure 6D). The enhanced
leptin sensitivity coincided with increased oxygen consumption
and energy expenditure; no difference was noted in ambulatory
movement or food intake (Figure 6E). Somewhat surprisingly,
leptin levels trended higher in Nes-Cre;Ptpn2lox/lox mice (Fig-
ure 6G) despite their enhanced leptin sensitivity. Nonetheless,
insulin sensitivity (ITTs) in neuronal TCPTP-deficient mice was
enhanced (Figure 6F), and this coincided with reduced fasted
blood glucose levels and insulin levels (Figure 6G). Consistent
with this, adiponectin levels remained elevated in HFFwith saline or GH (0.5 mg/g i.p.). Hypothalami were extracted and processed for
)andphosphorylated (Y694)STAT5 (p-STAT5)and reprobed forSTAT5andactin.
(at 8 a.m.) and processed for real-time PCR to measure Ghrh, Ghr, and Sst1
independent experiments; quantified results aremeans ± SEM for the indicated
etabolism 14, 684–699, November 2, 2011 ª2011 Elsevier Inc. 689
Figure 3. Neuronal TCPTP Deficiency Enhances Leptin Sensitivity
(A) Fed plasma leptin and adiponectin in 8- to 10-week-old male lox/lox and NTKO mice.
(B–D) Eight- to ten-week-old male lox/lox, NTKO, Ptpn2lox/+ (lox/+), and Nes-Cre;Ptpn2lox/+ (Cre;lox/+) mice were administered leptin, and body weight and food
intake were monitored as indicated. (B) and (D) were undertaken at the same time, and the NTKO data set is the same in both.
(E–G) Eight- to ten-week-old male lox/lox and NTKO mice were fasted for 18 hr and injected with saline or leptin. Hypothalami were extracted and processed for
immunoblot analysis with antibodies to p-STAT3, p-JAK2, or Ser473 phosphorylated Akt (p-Akt) and reprobed as indicated (E), paraformaldehyde (PFA)-perfused
Cell Metabolism
TCPTP and Leptin Sensitivity
690 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 Elsevier Inc.
Figure 4. Selective Regulation Leptin-Induced STAT3 Signaling
(A) CHO-LEPR-B cells transfected with vector control or constructs for the expression of 45 kDa TCPTP (TC45) were serum starved and stimulated with murine
leptin and processed for immunoblot analysis.
(B) CHO-LEPR-B cells transfected with constructs for the expression of wild-type TC45, or TC45-D182A ‘‘substrate-trapping’’ mutant, were serum starved,
stimulated with leptin for the indicated times, processed for immunofluorescence microscopy with antibodies to p-STAT3 and TCPTP, and stained with Hoechst
to visualize nuclei.
(C and D) SK-N-SH-SY5Y cells transduced with control or TCPTP shRNA lentiviral particles were serum starved, stimulated with leptin, and processed for
immunoblot analysis (C) or immunofluorescence microscopy (D). Results are representative of at least three independent experiments; quantified results are
means ± SEM.
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TCPTP and Leptin SensitivityNes-Cre;Ptpn2lox/lox mice (Figure 6G); TNF, which is also
produced by adipose tissue in obesity, was unaltered, indicating
that adipokines were not, in general, increased by TCPTP defi-
ciency (Figure 6G). Taken together these results indicate that
TCPTP deficiency enhances leptin sensitivity, decreases weight
gain, and prevents the development of insulin resistance induced
by high-fat feeding.brains were extracted and processed for immunohistochemistry with antibodies t
time PCR to measure Pomc, Agrp, and Npy expression (G). In (F), p-STAT3-pos
(H) Hypothalamic slices from 8- to 10-week-old male lox/lox and NTKO mice w
100 nM) for 45 min. Secreted NPY and a-MSH were measured by radioimmunoa
experiments; quantified results are means ± SEM for the indicated number of m
Cell MHypothalamic PTP1B, SOCS3, and TCPTP Expression
PTP1B and SOCS3 exert their effects on the leptin pathway
through the dephosphorylation and inactivation of JAK2 and
would thus act upstream of TCPTP, which can dephosphorylate
STAT3 in the nucleus. In HFF Nes-Cre;Ptpn2lox/lox mice, we
noted a point of inflection at approximately 7 weeks on diet, so
that the benefit of TCPTP deficiency in the prevention of DIOo p-STAT3 (F), or hypothalami were extracted after 2 hr and processed for real-
itive nuclei in the ARC, DMH, or VMH were counted in serial sections.
ere incubated in aCSF for 45 min (basal) and then stimulated with leptin (20–
ssay. Results in (A)–(E) and (G) and (H) are representative of three independent
ice.
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Figure 5. Inhibition of Neuronal TCPTP Enhances Leptin Sensitivity
(A) Twelve-week-old C57BL/6 male mice were fasted for 18 hr, administered aCSF or TCPTP inhibitor compound 8 (Comp. 8) i.c.v., and then injected with saline
or leptin as indicated. Hypothalami were extracted and processed for immunoblotting.
(B and C) Twelve-week-old C57BL/6 male mice were injected with saline or leptin as indicated, and body weights, oxygen consumption, and energy expenditure
were monitored.
(D) Twelve-week-oldmale lox/loxandNTKOmicewere i.c.v.administeredaCSForComp.8and injectedwith leptinas indicated, andbodyweightsweremonitored.
In (B), significance values correspond tomice treatedwith aCSF+Leptin versusComp. 8 + Leptin, and in (D),mice treatedwith lox/lox (Leptin + aCSF) versusNTKO
(Leptin + aCSF). Results are representative of at least two independent experiments; quantified results are means ± SEM for the indicated number of mice.
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that an increase in hypothalamic PTP1B and/or SOCS3 expres-
sion might account for this phenomenon. To examine this we
compared TCPTP, PTP1B, and SOCS3 expression in the hypo-
thalami of C57BL/6 mice fed a high-fat diet for 0, 3, 6, 9, and
12 weeks (Figure 7A). We noted that increases in SOCS3 and
PTP1B expression first occurred at 6 weeks, followed by
increases in TCPTP at 9 weeks of high-fat feeding (Figure 7A).
The increase in hypothalamic TCPTP coincided with a significant
rise in plasma leptin levels at 9 weeks of high-fat feeding (Fig-
ure 7B), whereas the increase in PTP1B and SOCS3 coincided
with a rise in circulating proinflammatory cytokines IL-6 and
TNF at 3–6 weeks of high-fat feeding (Figure 7C). These results
are consistent with increases in PTP1B, SOCS3, and TCPTP
coordinately contributing to the high-fat-diet-induced develop-
ment of cellular leptin resistance, with SOCS3 and PTP1B
acting early, driven by the developing inflammation, and TCPTP
later, driven by the hyperleptinemia to exacerbate disease
progression.
Neuronal PTP1B and TCPTP Double Knockout Mice
To test whether increases in hypothalamic PTP1B and TCPTP
might additively contribute to the development of cellular leptin692 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 Elsevierresistance in obesity, we generated mice that lacked PTP1B
alone (data not shown) or PTP1B and TCPTP in neuronal cells
(Figure 7D and Supplemental Experimental Procedures). At
3 weeks of age, the combined deficiency in PTP1B and TCPTP
led to additive effects on body weight and length that persisted
at 8 weeks of age (Figures 7E and 7F). At 8 weeks, male
PTP1B and TCPTP double knockout (DKO) mice were propor-
tionately smaller with no overt effect on bone density, lean
mass, or fat mass (assessed by DEXA) when normalized for total
body weight (Figure 7G). DKO had enhanced leptin sensitivity
and lower plasma leptin levels (Figure 7H), improved insulin
sensitivity and lower fasted blood glucose levels (Figure 7I),
significantly enhanced oxygen consumption and energy expen-
diture and decreased food intake, but unaltered ambulatory
activity (Figure S6). Interestingly, the respiratory exchange ratios
(RERs; a measure of carbohydrate and fat oxidation) in DKO
mice were decreased in the light cycle and increased in the
dark cycle (Figure S6), consistent with DKO mice utilizing more
fat during the day and carbohydrate at night when the mice
are more active. Mice that lacked PTP1B alone (Nes-Cre;
Ptpn1lox/lox) had reduced plasma leptin, enhanced leptin sensi-
tivity (Figure 7H), and improved insulin sensitivity (Figure 7I),
but these effects were not as pronounced as in DKO mice;Inc.
Figure 6. TCPTP-Deficient Mice Are Resistant to DIO
(A–G) Eight- to ten-week-old male lox/lox and NTKOmice were HFF for 12 weeks. Body weights were measured on a weekly basis, and the incremental increase
in body weight was determined (A). Body composition wasmeasured by DEXA (B). Mice were administered leptin as indicated, and body weights weremonitored
(C). Mice were fasted for 18 hr and injected with saline or leptin, and hypothalami were extracted and processed for immunoblot analysis (D). Oxygen
consumption, energy expenditure, and ambulatory activity were determined, and daily food intake was measured (E). Mice were fasted and ITTs performed;
areas under ITT curves were determined (F). Fed and fasted blood glucose and plasma insulin levels and fed plasma leptin, adiponectin, and TNF levels were
measured (G). Results are representative of three independent experiments; quantified results are means ± SEM for the indicated number of mice.
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Figure 7. Increases in Hypothalamic PTP1B and TCPTP Contribute to DIO
(A–C) Eight-week-old C57BL/6 male mice were HFF for 0–9 weeks, and hypothalami were isolated and processed for immunoblot analysis for an assessment
of PTP1B, TCPTP, and SOCS3 levels (A), or mice were bled to measure plasma leptin, TNF, and IL-6 levels (B and C).
(D) Ptpn1lox/loxPtpn2loxlox and neuronal cell TCPTP and PTP1B double KO mice (Nes-Cre;Ptpn1lox/loxPtpn2loxlox; DKO) were generated, and whole brains
or hypothalami (Hypo) were extracted for an assessment of PTP1B and TCPTP protein levels.
(E and F) Body weights (E) or body lengths (nose to tail, F) in male Ptpn1lox/lox, Ptpn2loxlox, Ptpn1lox/loxPtpn2loxlox, Nes-Cre;Ptpn1lox/lox, Nes-Cre;Ptpn2loxlox, and
DKO mice.
(G) Body composition in 8- to 10-week-old male Ptpn1lox/loxPtpn2loxlox and DKO measured by DEXA and normalized to total body weight.
(H) Eight-week-old male mice were administered leptin as indicated, and body weights were monitored. Fed plasma leptin levels were determined.
Cell Metabolism
TCPTP and Leptin Sensitivity
694 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 Elsevier Inc.
Cell Metabolism
TCPTP and Leptin SensitivityNes-Cre;Ptpn1lox/loxmice also exhibited trends for reduced food
intake and increased energy expenditure and activity, but had
unaltered RERs (data not shown). Double floxed and DKO
mice were placed on a high-fat diet, and the incremental
increase in body weight was monitored for up to 9 weeks (Fig-
ure 7J). The combined deletion of TCPTP and PTP1B led to
a significantly greater reduction in high-fat-diet-induced weight
gain than deletion of PTP1B alone (Figure 7J), and this was asso-
ciated with a decrease in fat accumulation in DKO mice (Fig-
ure 7K). HFF DKO mice had significantly enhanced leptin sensi-
tivity (Figure 7L) and improved glucose homeostasis (Figure 7M).
In contrast, mice lacking PTP1B alone exhibited only a modest
increase in leptin sensitivity and a trend for enhanced insulin
sensitivity (Figures 7L and 7M); leptin levels trended higher in
both HFF DKO and Nes-Cre;Ptpn1lox/lox mice (Figure 7M), as
seen in neuronal cell-specific TCPTP-deficient mice (Figure 6G).
Importantly, the inflection in weight gain noted in neuronal cell-
specific TCPTP-deficient mice at 6–7 weeks of age (Figure 6A)
was not evident in HFF DKO mice (Figure 7J). These results
are consistent with increases in hypothalamic PTP1B and
TCPTP in obesity additively attenuating the leptin response for
the promotion of cellular leptin resistance and obesity.
DISCUSSION
Leptin integrates the status of peripheral fat stores with the
central control of energy expenditure and food intake for the
homeostatic control of body weight. In normal-weight individ-
uals, complex biological mechanisms protect against both
weight gain and weight loss to stabilize fat stores and ensure
survival and reproductive fitness. Specific feedback mecha-
nisms exist to protect against excessive weight loss that may
otherwise be associated with prolonged leptin signaling (Myers
et al., 2008). In this study, we demonstrate that the tyrosine-
specific phosphatase TCPTP serves in a negative feedback
loop for the inhibition of leptin signaling. We report that hypotha-
lamic TCPTP expression is induced by leptin and that elevated
leptin levels in obesity result in increased TCPTP to exacerbate
the development of cellular resistance and progression toward
morbid obesity. Therefore, our studies identify TCPTP as a
member of regulatory triad that includes PTP1B and SOCS3
and functions to comprehensively attenuate the leptin response
in obesity by inhibiting signaling at the receptor, JAK2, and
STAT3.
Leptin exerts its effects on bodyweight via the activation of the
tyrosine kinase JAK2 that phosphorylates STAT3 and in parallel
activates the Ras/MAPK and PI3K/Akt pathways (Myers et al.,
2008). Importantly, STAT3 can elicit changes in Pomc and
Agrp but not Npy expression (Bates et al., 2003). In this study,
we found that TCPTP attenuated leptin-induced STAT3 but not
Akt or ERK1/2 signaling in cell culture systems in vitro, and(I) ITTs in 8-week-old male mice; areas under ITT curves were determined. Fed a
(J) The indicated 8- to 10-week-old male mice were HFF, and the incremental in
(K) Relative lean and fat masses in HFF Ptpn1lox/loxPtpn2loxlox and DKO measure
(L) Leptin sensitivity was assessed, and fed plasma leptin levels were determine
(M) ITTs were performed, and fasted blood glucose levels were determined in H
quantified results are means ± SEM for the indicated number of mice; n.s.: not sig
# to Ptpn1loxlox versus Nes-Cre;Ptpn1lox/lox mice, and q to Nes-Cre;Ptpn1lox/lox ve
Cell Mthat TCPTP dephosphorylated STAT3 in the nucleus. Moreover,
we found that leptin-induced hypothalamic STAT3 signaling and
responses were elevated in neuronal cell-specific TCPTP-defi-
cient mice in the ARC and VMH and that this was associated
with changes in Pomc and Agrp but not Npy expression/secre-
tion. Hence, our studies are consistent with TCPTP selectively
regulating leptin-induced STAT3 signaling in vivo. Previous
studies have established that PTP1B, but not TCPTP, dephos-
phorylates and inactivates JAK2 (Myers et al., 2001; Simoncic
et al., 2002). Moreover, PTP1B and TCPTP can function cooper-
atively in cells in vitro to regulate the phosphorylation of JAKs
and STATs in the cytoplasm and nucleus, respectively (Lu
et al., 2007, 2008; Sharma et al., 2008; Simoncic et al., 2006).
Accordingly, we propose that the two phosphatases act to coor-
dinately regulate leptin signaling in vivo: PTP1B attenuating
JAK2 phosphorylation and possibly STAT3 in the cytoplasm,
and TCPTP dephosphorylating STAT3 in the nucleus.
As reported previously for Nes-Cre;Ptpn1lox/lox mice (Bence
et al., 2006), neuronal cell-specific TCPTP-deficient mice were
proportionately smaller than their floxed littermates. Although
recent studies by Briancon et al. (Briancon et al., 2010) have re-
ported that some strains of Nes-Cre mice exhibit a phenotype
(being smaller than wild-type mice), this was not evident in our
studies. We noted no overt difference in body weight, leptin
sensitivity, or glucose homeostasis in hemizygous Nes-Cre;
Ptpn2lox/+ mice or Nes-Cre;Ptpn2+/+ mice, consistent with
previous studies using the same Nes-Cre strain (Bence et al.,
2006). Moreover, we found that the combined deficiency of
PTP1B and TCPTP had additive effects on body weight and
size. Our studies suggest that the size difference in Nes-Cre;
Ptpn1lox/lox mice might be due to perturbations in the GH/IGF-1
axis. Previous studies have shown that PTP1B can dephosphor-
ylate JAK2, STAT5, and the IGF-1 receptor (IGF-1R) in cells to
attenuate GH and IGF-1 signaling (Aoki and Matsuda, 2000;
Gu et al., 2003; Myers et al., 2001), whereas TCPTP has the
capacity to dephosphorylate STAT5 (but not JAK2 or IGF-1R)
(Aoki and Matsuda, 2002; Buckley et al., 2002; Simoncic et al.,
2002). We found that GH and IGF-1 levels were decreased in
TCPTP knockout (Nes-Cre;Ptpn2lox/lox) mice and that hypotha-
lamic STAT5 phosphorylation was enhanced in response to
bolus GH administration. Increased STAT5 phosphorylation in
the hypothalamus would inhibit GH release from the pituitary,
thus perturbing the GH/IGF-1 axis (Becker et al., 1995; Burton
et al., 1992; Minami et al., 1993; Romero et al., 2010). We
suggest that the lower circulating GH and IGF-1 levels account
for the decreased size and the increased relative adiposity in
chow-fed Nes-Cre;Ptpn2lox/lox mice, as GH promotes postnatal
skeletal growth and lipolysis (Lichanska and Waters, 2008).
Recent studies have also reported that neuronal cell-specific
PTP1B knockout mice have reduced circulating IGF-1 (Briancon
et al., 2010). We expect that the combined deficiency of PTP1Bnd fasted blood glucose levels were measured.
crease in body weight was determined.
d by DEXA.
d in HFF mice.
FF mice. Results are representative of at least two independent experiments;
nificant. In (J) and (L), * corresponds to Ptpn1lox/loxPtpn2loxlox versus DKOmice,
rsus DKO mice.
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IGF-1 levels, compounding the effects on body size.
Several lines of evidence support the conclusion that TCPTP
acts as a key regulator of hypothalamic leptin signaling. First,
TCPTP expression was increased transiently in the hypothalami
of C57BL/6 mice in response to bolus leptin administration and
in LEPR-B-expressing cells treated with leptin, consistent with
TCPTP serving in a feedback loop. Second, despite the de-
creased ambulatory activity and increased relative adiposity,
Nes-Cre;Ptpn2lox/lox mice had significantly lower circulating lep-
tin levels and lower fasting blood glucose and insulin levels,
consistent with enhanced leptin and insulin sensitivity. This is
particularly striking and suggests that the impact of TCPTP defi-
ciency on leptin sensitivity and the central control of glucose
homeostasis overrides the increase in leptin production and
the development of peripheral insulin resistance that would
otherwise be expected with increased adiposity. Third, despite
the decreased ambulatory activity,Nes-Cre;Ptpn2lox/loxmice ex-
hibited increased oxygen consumption and energy expenditure
(corrected for body weight) and decreased food intake, as might
be expected for enhanced leptin sensitivity. Fourth, the reduc-
tion in food intake and body weight after leptin administration
was significantly enhanced by TCPTP deficiency in both chow
and HFF mice. Fifth, hypothalamic STAT3 phosphorylation was
significantly enhanced in the ARC and VMH after leptin adminis-
tration, coinciding with significant changes in Pomc and Agrp
expression in Nes-Cre;Ptpn2lox/lox mice. The increase in leptin-
induced signaling could be recapitulated in vitro in cells of neu-
ronal origin after TCPTP knockdown. Sixth, TCPTP deficiency
enhanced the leptin-induced a-MSH secretion from hypotha-
lamic slices ex vivo, making any extrinsic influences that may
be associated with the differences in body weight in the whole
animals unlikely. Finally, the effects of TCPTP deficiency could
be recapitulated by the i.c.v. administration of a specific TCPTP
inhibitor. Inhibition of TCPTP in C57BL/6 mice enhanced leptin-
induced hypothalamic STAT3 signaling and increased the
effects of leptin on body weight and energy expenditure. Impor-
tantly, the inhibitor did not have any overt effect on leptin-
induced responses in Nes-Cre;Ptpn2lox/lox mice, consistent
with the inhibitor being specific for TCPTP. Taken together, these
studies provide compelling evidence for TCPTP being a key
regulator of central leptin sensitivity.
Our studies indicate that increased hypothalamic TCPTP
contributes to cellular leptin resistance in obesity. In HFF
C57BL/6 mice, increased hypothalamic TCPTP coincided with
increased circulating leptin. The increase in TCPTP was pre-
ceded by increases in hypothalamic PTP1B and SOCS3 that
coincided with elevated circulating TNF and IL-6. Zabolotny
et al. (Zabolotny et al., 2008) have reported that hypothalamic
PTP1B expression can be driven by TNF in vivo, whereas hypo-
thalamic SOCS3 expression can be induced by IKKb/NF-kB
signaling (Zhang et al., 2008), an effector pathway of TNF.
Accordingly, we suggest that cellular leptin resistance and
obesity develop along a continuum, with inflammation associ-
ated with high-fat feeding at first promoting hypothalamic
PTP1B and SOCS3 to attenuate JAK2 and reduce leptin sensi-
tivity to consequently increase adiposity and circulating leptin
to promote hypothalamic TCPTP expression. The increased
TCPTP would in turn dephosphorylate STAT3 to further atten-696 Cell Metabolism 14, 684–699, November 2, 2011 ª2011 Elsevieruate the leptin response and contribute to the development of
overt cellular leptin resistance and progression to morbid
obesity. Although one might expect that the hyperleptinemia
should compensate for the developing leptin resistance, it is
possible that leptin signaling pathways and/or leptin-responsive
neurons may be differentially sensitive to leptin. In keeping with
this possibility, some leptin functions, such as leptin’s cardiovas-
cular effects, remain intact in the leptin-resistant state (Correia
et al., 2002; Rahmouni et al., 2005). In the case of TCPTP, it is
important to note that TCPTP has a long protein half-life (Bukc-
zynska et al., 2004) so that the sustained hyperleptinemia in
obesity may be sufficient to promote andmaintain TCPTP levels.
However, we cannot exclude the possibility that in the obese
state, additional molecular factors, which by themselves have
no effect, contribute to the promotion of TCPTP expression.
Nevertheless, consistent with increases in hypothalamic TCPTP
and PTP1B coordinately contributing to the onset and progres-
sion of cellular leptin resistance, we found that the combined
ablation of TCPTP and PTP1B had additive effects in protecting
mice from high-fat-diet-induced weight gain. Briancon et al.
(Briancon et al., 2010) have reported that the combined inactiva-
tion of PTP1B and SOCS3 in neuronal cells decreases adiposity
and improves glucose tolerance, with minimal if any impact on
high-fat-diet-induced or age-associated weight gain. In our
studies we found that the combined deletion of PTP1B and
TCPTP had a pronounced effect on high-fat-diet-induced weight
gain, but did not completely protect mice. The latter may be
attributable to varied factors, which include increases in
SOCS3, the hedonistic attractiveness of a high-fat diet, and/or
gliosis and changes in the blood brain barrier that may impair
leptin’s access to neurons in the ARC (El-Haschimi et al., 2000;
Horvath et al., 2010).
The results of this study define the role of TCPTP in the central
control of leptin signaling and delineate a negative feedback
loop that functions together with PTP1B and SOCS3 for the
attenuation of the leptin response. Importantly, our results indi-
cate that increases in hypothalamic TCPTP may be causally
linked to the attenuation of leptin sensitivity working in conjunc-
tion with PTP1B for the coordinated suppression of JAK2/
STAT3 signaling and the promotion of cellular leptin resistance.
Our studies underscore the highly specific nature of phospha-
tases such as PTP1B and TCPTP in vivo and highlight their
capacity to work in concert for the comprehensive regulation
of signaling networks and biological responses. Moreover, our
findings indicate that the combined inhibition of PTP1B and
TCPTP might be required for the effective alleviation of cellular
leptin resistance in obesity, and therapeutic approaches
currently aimed at targeting PTP1B should take this into
consideration.EXPERIMENTAL PROCEDURES
Mice
We maintained mice on a 12 hr light-dark cycle in a temperature-controlled
high-barrier facility (Monash ARL) with free access to food and water accord-
ing to NHMRC Australian Code of Practice for the Care and Use of Animals.
The Nes-Cre (originating from R. Klein, Max Planck Institute of Neurobiology)
backcrossed for six generations onto the C57BL/6J background have been
described previously (Bence et al., 2006). Ptpn2lox/+ (C57BL/6) were gener-
ated as described in Supplemental Experimental Procedures and matedInc.
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a standard chow (19% protein, 4.6% fat, and 4.8% crude fiber) or a high-fat
diet (23% fat; 45% of total energy from fat; SF04-027; Specialty Feeds) as
indicated.
Lateral Ventricle Cannulation
Cannulas were stereotaxically inserted (1.0 mm lateral and 0.3 mm rostral to
bregma) as described in Supplemental Experimental Procedures. After
recovery, mice were fasted and aCSF or compound 8 (1.5 ml, 0.2 nmol) was
administered i.c.v. prior to saline or leptin injection (1 mg/g, i.p.) for 45 min.
Mice were sacrificed by cervical dislocation and hypothalami were isolated.
For leptin sensitivity assays, mice were i.c.v. injected with either aCSF or
TCPTP inhibitor and saline or leptin at 7 a.m. and 7 p.m. for 2 consecutive
days, and body weight, oxygen consumption, and energy expenditure were
recorded.
Hypothalamic Peptide Secretion
Mice were decapitated and whole brains were removed for the isolation of
hypothalami, and 2mm thick slices ofmediobasal forebrain including the para-
ventricular and arcuate nuclei were prepared using a vibrating microtome
and processed for peptide secretion assays as described in Supplemental
Experimental Procedures.
ARC and VMH Microdissection
Isolated brains were frozen and sectioned at 300 mm in a cyrostat and
collected on microscope slides. The sections were briefly warmed and refro-
zen to adhere to slides. The ARC, VMH, DMH, PVN, LH, and cortex were iden-
tified using a surgical microscope. A blunted 21G needle was used to punch
out frozen brain regions. The ARC was collected from three consecutive
sections, the VMH from four consecutive sections, and the DMH, PVN, and
LH punched out of two consecutive sections each.
Immunohistochemistry
Animals were anesthetized with isoflurane and perfused with PBS and then
4% PFA. Brains were postfixed in 4% PFA overnight, then placed in sucrose
and cut at 40 mm on a cryostat. We performed immunohistochemistry to
monitor for p-STAT3 and POMC neurons as described previously (Andrews
et al., 2008). STAT3 phosphorylation was quantified in neurons in the
ARC (Br 1.22 to 2.54), the VMH (Br 1.22 to 2.06), and DMH (Br 1.46
to 2.18). p-STAT3-positive cells were visualized on a Zeiss microscope
(Carl Zeiss) and counted in serial sections throughout the hypothalamus using
a grid eye piece.
Metabolic Measurements and Body Composition
Insulin and glucose tolerance tests and blood glucose and plasma insulin and
adipokine analyses were performed as described previously (Loh et al., 2009).
For leptin sensitivity assays, mice were administered recombinant mouse lep-
tin (i.p.) at 9:30 a.m. and 7:30 p.m. for 3 days in a row, and body weights and
food intake were recorded daily at 1 p.m. for up to 9 days. Body weight and
baseline food intake for the 3 days prior to the start of the experiment were
averaged and used to calculate the percent change. Activity, food intake,
and energy expenditure were assessed using a Comprehensive Lab Animal
Monitoring System (Columbus Instruments), and body composition was deter-
mined by DEXA (Lunar PIXImus2; GE Healthcare) as described in Supple-
mental Experimental Procedures.
Cell Culture and Immunofluorescence Microscopy
SK-N-SH-SY5Y neuroblastoma cells and CHO-LEPR-B cells were cultured as
described in Supplemental Experimental Procedures. Control SK-N-SH-SY5Y
cells and those expressing TCPTP-specific shRNAs were generated as
described previously (Shields et al., 2008). CHO-LEPR-B cells were trans-
fected with pCG, pCG-TC45, or pCG-TC45-D182A using Lipofectamine
2000 (Invitrogen). SK-N-SH-SY5Y and CHO-LEPR-B cells were serum starved
for 6 hr and then stimulated with 100 ng/ml human and 0.1 ng/ml murine leptin,
respectively, for the indicated times. Where indicated, SK-N-SH-SY5Y and
CHO-LEPR-B were fixed with 3.2% PFA and processed for immunofluores-
cence microscopy as described previously (Tiganis et al., 1998).Cell MBiochemical Analyses
Mouse tissues were dissected and immediately frozen in liquid N2. Tissues
were mechanically homogenized in ice-cold RIPA lysis buffer and pro-
cessed for immunoblot analysis as described in Supplemental Experimental
Procedures.Real-Time PCR
Hypothalami were dissected and immediately frozen in liquid N2, and RNAwas
extracted using TRIzol reagent and processed for quantitative real-time PCR
using TaqMan Gene Expression Assays (Applied Biosystems) as described
in Supplemental Experimental Procedures. Reactions were performed in trip-
licate, and relative quantification was achieved using the DDCt method.Statistical Analyses
All data were presented as means ± SEM, and statistical significance was
determined using the Student’s t test or two-way ANOVA; p < 0.05 was consid-
ered significant.SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, Supplemental Experimental
Procedures, and Supplemental References and can be found with this article
online at doi:10.1016/j.cmet.2011.09.011.ACKNOWLEDGMENTS
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